Identification of novel members of the bacterial azoreductase family in 'Pseudomonas aeruginosa' by Crescente, Vincenzo et al.
Identification of novel members of the bacterial azoreductase family in 
Pseudomonas aeruginosa 
Authors: Vincenzo Crescente; Sinead M. Holland; Sapna Kashyap; Elena Polycarpou; Edith Sim; Ali 
Ryan1  
*Faculty of Science, Engineering and Computing, Kingston University, Penhryn Road, Kingston-upon-
Thames, UK, KT1 2EE 
1 Corresponding author: Dr Ali Ryan, e-mail: a.ryan@kingston.ac.uk. 
Knowledge Environment: BJ Biomolecules 
Running title: Characterisation of novel bacterial azoreductases 
Abstract:  
Azoreductases are a family of diverse enzymes found in many pathogenic bacteria as well as distant 
homologues being present in eukarya. In addition to having azoreductase activity these enzymes are 
also suggested to have NAD(P)H quinone oxidoreductase activity which leads to a proposed role in 
plant pathogenesis. Azoreductases have also been suggested to play role in the mammalian 
pathogenesis of Pseudomonas aeruginosa. In view of the importance of P. aeruginosa as a pathogen, 
we therefore characterised recombinant enzymes following expression of a group of putative 
azoreductase genes from P. aeruginosa expressed in Escherichia coli. The enzymes include members 
of the “Arsenic resistance protein H” (ArsH), “tryptophan repressor binding protein A” (WrbA), 
“modulator of drug activity B” (MdaB) and YieF families. The ArsH, MdaB and YieF family members 
all show azoreductase and NAD(P)H quinone oxidoreductase activities. In contrast, WrbA is the first 
enzyme to show NAD(P)H quinone oxidoreductase activity but does not  reduce any of the 11 azo 
compounds tested under a wide range of conditions.  These studies will allow further investigation 
of the possible role of these enzymes in the pathogenesis of P. aeruginosa. 
Keywords: azoreductase, Pseudomonas aeruginosa, mammalian infection, modulator of drug 
activity B, YieF, ArsH.1 
Summary Statement 
Azoreductases are a family of enzymes found in many pathogenic bacteria. Members of this family 
are required for pathogenicity in Pseudomonas aeruginosa. Three novel classes of azoreductases 
were characterised, aiding in the identification of enzymes for bioremediation. 
  
                                                          
1
 Aqn: anthraquinone-2-sulphonate, ArsH: Arsenic resistance protein H, Bzq: Benzoquinone, Dcb: 2,5-
dichlorobenzoquinone, DSF: Differential scanning fluorimetry, Ibc: 2,6-dichloroquinone-4-chloromide, Jug: 
Juglone, Law: Lawsone, MdaB: Modulator of drug activity B, Men: Menadione NQO: NAD(P)H quinone 
oxidoreductase, Onq: 1,2-napthoquinone, paAzoR: P. aeruginosa azoreductase, Phb: Phenol blue, Plu: 
Plumbagin, TM: melting temperature, and WrbA: Tryptophan repressor binding protein A. 
Introduction 
Azoreductases are a group of flavoenzymes which have been characterised in both aerobic [1] and 
anaerobic bacteria [2] as well as higher organisms such as yeast [3] and mammals [4]. Although 
these enzymes are found ubiquitously in bacterial genomes and are constitutively expressed in vitro 
[5-9], their physiological role remains unclear. To date their role has been tied to their participation 
in the detoxification of cytotoxic quinones produced as antibacterial compounds by many plants [1]. 
A transcriptome study in Salmonella typhimurium has shown >100-fold up-regulation of an 
azoreductases during growth in lesions on cilantro and lettuce leaves versus in vitro growth [10]. A 
second study also showed significant up-regulation of Escherichia coli azoreductase during infection 
of radishes [6]. Studies in Pseudomonas aeruginosa using single gene deletion mutants have shown 
that azoreductase 1 (paAzoR1) is required for systemic infection of mice by a clinical strain  of P. 
aeruginosa  [11]. In addition both paAzoR1 and azoreductase 2 (paAzoR2) are required for systemic 
infection of mice by P. aeruginosa PA14 [12]. Taken as a whole, this data suggests a role for 
azoreductases in bacterial pathogenicity.   
One of the reasons for the lack of understanding of the physiological role of this enzyme family is 
that in addition to azo compounds (Sup Fig 1) they reduce a broad range of substrates, including 
quinones [13] and nitrofurans [14]. As a result of their azoreductase activity much research has 
focused on the identification of azoreductases for the bioremediation of azo dye containing waste 
waters [15, 16] and engineering of these enzymes for this purpose [17]. The identification of novel 
families of enzymes able to reduce azo compounds would allow the exploration of a much wider 
variety of enzyme for the use in bioremediation and may allow dual use enzymes as some 
azoreductase-like enzymes can reduce heavy metals [18].  
Mechanistic studies identified a common mechanism for the reduction of azo and quinone 
substrates [13, 19] and led to the proposition that azoreductases (EC: 1.7.1.6) and NAD(P)H quinone 
oxidoreductases (EC: 1.6.99.2) are members of a single superfamily [1]. One of the reasons these 
two functional classes were kept separate is the sequence diversity among the members. Proteins 
with sequence identities of <10% can have the same overall fold [1] and the same enzymatic 
activities. This makes identification of family members via bioinformatics challenging. A recent re-
evaluation of the available data [1] provided evidence that the azoreductase family is significantly 
larger than previously thought. The superfamily is proposed to incorporate a number of previously 
distinct enzyme families including the Modulator of drug activity B (MdaB), tryptophan repressor 
binding protein A (WrbA), YieF (also known as ChrR) and ArsH families. In total seven new 
azoreductases were predicted to be encoded by the P. aeruginosa PAO1 genome via an improved 
bioinformatics method (Table 1 [1]). In view of the challenging nature of the bioinformatics work, 
and the low level of sequence identity, it is important to test the hypothesis by determining whether 
the putative enzymes do have the activities proposed. We have therefore undertaken to 
characterise the azoreductases identified through bioinformatics and describe here the 
characterisation of 4 members of the MdaB, ArsH, WrbA and YieF, families encoded by P. 
aeruginosa. We have chosen these enzymes initially since these families occur in the genomes of 
many bacterial species [20-23].  
  
 
 
 
 
 
Experimental: 
All chemicals were obtained from Sigma Aldrich unless specified. NADH, NADPH and IPTG were 
purchased from Apollo Scientific, FMN and FAD were obtained from Tokyo Chemical Industries. 
Restriction enzymes were purchased from New England Biolabs.  
Cloning of azoreductases 
Genomic DNA was extracted from overnight cultures of P. aeruginosa PAO1 grown in LB at 37°C 
using a Gentra Puregene Yeast/Bacteria kit (Qiagen) and was used as a template to amplify the 
genes pa0949 (paWrbA), pa1204 (paYieF), pa2280 (paArsH) and pa2580 (paMdaB). PCR was 
performed using a Hotstar Hifidelity Taq kit (Qiagen) and the primers described in supplementary 
table 1. All PCR products were digested using NdeI and SacI prior to cloning into a similarly digested 
pET-28b plasmid (Novagen). Ligation of the genes into pET-28b was performed using T4 DNA ligase 
(Promega) and pET-28b including azoreductase genes were transformed into E. coli JM109 
(Promega). Transformants were selected on LB agar containing 30 g/mL kanamycin. The sequences 
of all clones were confirmed (Eurofins MWG biotech) prior to transformation into E. coli BL-21 
(Promega). 
Expression and purification of azoreductases 
All azoreductase genes were expressed as described for paAzoR1-3 [19]. Briefly, E. coli BL-21 cells 
were grown in LB supplemented with 1 M Sorbitol, 2.5 mM betaine and 30 g/mL kanamycin. 
Cultures were grown to an OD600 0.4-0.5 and induced with 0.5 mM IPTG for 16 hours at 18 °C.  
Cultures were centrifuged for 20 minutes at 6,000 g at 4°C and supernatant removed. Cells were 
then resuspended in lysis buffer containing complete protease inhibitors (Roche) sonication. The 
suspension was the centrifuged at 16,000 g to remove debris and the clarified supernatant applied 
to a Ni-NTA (Invitrogen) column. Protein was eluted via increasing imidazole concentration in the 
elution buffer from 0-250 mM stepwise. The exception being paYieF which required a 500 mM 
imidazole wash for complete elution.  
Prior to storage, all samples containing pure azoreductase were dialysed overnight against 20 mM 
Tris-HCl pH 8, 100 mM NaCl at 4°C in 14 kDa cutoff dialysis tubing. Protein concentration and overall 
yield were determined using the following 280 values obtained using Protparam [24]: paWrbA - 
16,055 M-1cm-1, paYieF – 19,940 M-1cm-1, paArsH – 29,575 M-1cm-1 and paMdaB - 39,420 M-1cm-1. All 
samples were aliquoted and stored at -80°C in 5% (v/v) glycerol.  
UV/VIS Absorbance scans were performed on 100 L of 1 mg/mL azoreductase in a 1 mL cuvette in a 
M200 Infite Pro (Tecan) plate reader.  
TLC 
Flavin cofactors were identified via the use of TLC as described previously [25]. Briefly, a mobile 
phase of 2:1:1 mix of n-butanol: acetic acid: water was used with a 0.2 mm silica gel coated plate. 
Pure stocks of FMN and FAD were spotted as standards for comparison. Plates were visualised under 
UV illumination.      
Differential scanning fluorimetry (DSF)  
DSF was performed via a protocol similar to that described previously [26]. Azoreductases were 
diluted to 64 g/mL in 20 mM Tris-HCl pH 8, 100 mM NaCl. The buffer contained Sypro Orange 
(Invitrogen) and was supplemented with either 1 M or 20 M FMN or FAD as indicated. 
Fluorescence measurements were made in an Mx3005p qRT-PCR instrument (Stratagene) and the 
temperature was increased from 25-95°C at 1°C/min. Data analysis was performed in Graphpad 
Prism with fitting to a Boltzman sigmoidal function.  
Enzymatic assays 
The putative azoreductases were screened against a range of azo and quinone substrates (Sup Fig 2). 
Azoreductase and nitrofurazone reductase assays were performed in 100 L final volume with a 
reaction mixture as follows, 1.6-100 g/mL azoreductase, 50 M azo/nitrofuran substrate, 500 M 
NAD(P)H, 1 M FMN/FAD, in 20 mM Tris-HCl pH 8, 100 mM NaCl. The concentration of enzyme was 
adjusted to maintain a linear rate of reaction for 1 minute to allow accurate rate determination.  
Reactions were monitored at the optimal wavelength for each substrate in an M200 Infinite Pro 
plate reader (Tecan). Rates were determined over the initial linear portion of the graph. Quinone 
reductase assays were performed as described previously [14] with addition of 1 M flavin to the 
reaction buffer. 
The effect of FMN concentration on enzymatic activity was measured using Phenol Blue (Phb) as the 
substrate. The reaction mixture was as follows: 0.2-10 g/mL azoreductase, 100 M Phb, 500 M 
NAD(P)H, 1-20 M FMN/FAD, in 20 mM Tris-HCl pH 8, 100 mM NaCl. A fixed concentration of each 
azoreductase was used for assays at all concentrations of flavin. Phb reduction was measured via the 
change in absorbance at 660 nm.   
Homology modelling 
A homology model for paMdaB was generated using the phyre2 web server [27] in intensive mode. 
The paMdaB model was based upon the structures of MdaB from Yersiniae pestis (PDB: 3RPE – 59% 
identical) and E. coli (PDB: 2AMJ [28] – 61% identical). 
 
Results and Discussion 
Recombinant azoreductase expression 
High yields of pure recombinant paWrbA, paYieF, paArsH and paMdaB were obtained via growth and 
expression under the same conditions as previously used for paAzoR1-3 (Fig 1). Under these 
conditions the combination of E. coli BL-21 expression and His-tag purification yielded large 
quantities of pure protein (Fig 1) for all four azoreductases. The highest yield from a single culture 
was 54 mg paYieF (paWrbA 28 mg and paMdaB 30.2 mg) from 1 L E. coli culture.  
Nicotinamide cofactor selectivity 
As methyl red has previously been shown to be a good substrate for many proteins able to reduce 
azo compounds [19, 22] all four proteins were initially tested for their ability to reduce methyl red in 
the presence of a 5 fold molar excess of either NADH or NADPH (Fig 2). paArsH and paMdaB were 
able to reduce methyl red at a significantly higher rate when using NADPH compared to NADH as the 
nicotinamide cofactor (Fig 2C and 2D respectively).  
paYieF was unable to reduce methyl red under these conditions, however when it was tested for 
reduction of the quinone Men it was able to reduce it in the presence of both NADH and NADPH (Fig 
2B). In this case paYieF showed a significantly higher rate of reduction when using NADPH when 
compared to NADH. This is consistent with a previous study of paYieF which showed selectivity with 
NADPH [29]. Consistent with the absence of a flavin spot on the TLC plate (Sup Fig 3A), paWrbA was 
unable to reduce either quinones or azo compounds under these initial conditions. Instead it was 
necessary to add FMN to the reaction mixture to allow turnover. With the inclusion of FMN and 
using Men as a substrate paWrbA showed significantly higher rates of reduction of Men with NADPH 
as the hydride donor rather than NADH (Fig 2A).   
 
Flavin cofactor selectivity 
Prior to characterisation of the enzyme specificity it was necessary to ascertain whether flavin was 
present in the recombinant azoreductases. All enzymes were expected to be flavin-dependent 
azoreductases however whether flavin was incorporated during expression in E. coli was uncertain. 
UV/Vis spectra were collected for each of the expressed azoreductases (Sup Fig 4). paWrbA lacked 
the characteristic flavin absorption peaks found in other azoreductases [13]. The peaks were present 
in all of the other proteins but were not as well defined as one would expect. In order to further 
investigate the incorporation of flavin measurements of absorbance at both 280 nm (protein) and 
450 nm (flavin) were taken to determine the approximate protein:flavin molar ratio for the 
expressed proteins. One would expect a 1:1 protein:flavin molar ratio under ideal conditions [5], 
however the actual ratio varies from 3:1 (paMdaB) to 6:1 (paWrbA) which is consistent with the poor 
intensity of flavin peaks in the UV/Vis spectra. This result indicates that the flavin has either become 
dissociated from the expressed protein or was not sufficiently incorporated during expression. Loss 
or non-incorporation of flavin during recombinant expression is a frequent problem and is expected 
for these proteins as to obtain crystals of paWrbA and paYieF in complex with FMN it was necessary 
to soak preformed crystals in FMN prior to data collection [29, 30]. Dissociation of flavin from the 
azoreductases occurs because the flavin is not covalently bound to the enzyme [19].   
To confirm which flavin (FMN or FAD) was incorporated into the protein, samples were analysed via 
TLC (Sup Fig 3). Of the four enzymes paMdaB was the only one with an intense flavin spot via TLC 
(Sup Fig 3D), which suggests FAD incorporation into the enzyme. The selectivity of paMdaB for FAD 
and NADPH is consistent with the result from a study of E. coli MdaB (75% sequence similarity) that 
found the enzyme had the same cofactor preferences when reducing quinones [31]. In paWrbA and 
paArsH (Sup Fig 3A and C) a flavin spot was not present in the expressed protein and in paYieF the 
spot for FAD was very weak (Sup Fig 3B). 
A characteristic quenching of native flavin fluorescence was observed upon titration of the 
recombinant azoreductases suggesting binding of the flavin to the protein. DSF was used to monitor 
the effect of adding extra FMN or FAD on the stability of the azoreductases. Thermostability 
measurements for each of the azoreductases were performed in the presence and absence of flavin 
and the TM was measured (Table 2). An increase in TM upon addition of flavin would indicate flavin 
binding to the protein. The binding of flavin within the active site will significantly stabilise the 
structure of the azoreductase due to the number of hydrogen bonds formed between the flavin and 
the protein backbone [19].    
A significant thermal shift was observed upon addition of 1 M of either flavin to paMdaB however 
the shift was much larger with FAD than FMN (16°C with FAD compared to 5°C with FMN). This data 
combined with the appearance of an FAD spot on TLC (Sup Fig 3B) suggests that FAD is the cofactor 
used by paMdaB. paArsH shows a small but significant thermal shift as a result of addition of 1 M 
FMN however no change was observed upon addition of 1 M FAD. This suggests selective binding 
of FMN to the protein, which is consistent with results from ArsH in Sinorhizobium meliloti [32]. In 
the case of both paWrbA and paYieF no significant thermal shift was observed upon addition of 
either 1 or 5 M flavin and only after addition of 20 M flavin was a significant shift observed. 
paYieF was destabilised by addition of 20 M FMN, in contrast to a significant increase in 
thermostability (>6°C) resulting from the addition of 20 M FAD. This data in combination with a 
weak FAD spot on TLC (Sup Fig 3C) suggests that FAD is the cofactor used by paYieF. This is 
inconsistent with a previous crystallographic study where the structure of paYieF was solved with 
FMN bound at the active site [29], however as mentioned previously the FMN was added after 
crystal formation and no experimental evidence was provided for the addition of FMN over FAD. 
paWrbA was stabilised in the presence of both FMN and FAD however the stabilisation was far 
greater with FMN (12°C with FMN compared to 2°C with FAD) suggesting FMN would be selectively 
incorporated into paWrbA which is consistent with FMN being highly selectively incorporated into E. 
coli WrbA [23].  
In order to further analyse the flavin selectivity of the azoreductases we monitored the effect of 
addition of each flavin on azoreductase activity and this is covered in the NAD(P)H quinone 
oxidoreductase section.  
Azoreductase specificity profiles of the new enzymes 
paMdaB, paArsH, paWrbA and paYieF were screened against the same azo compounds which had 
previously been used to screen paAzoR1-3 (Sup Fig 2 [19]). Results showed that paMdaB, paArsH 
and paYieF were able to reduce a variety of azo compounds (Fig 3). As the enzymatic activity of 
paArsH has never been determined this data confirms its role as an azoreductase. In the cases of 
paMdaB and paYieF this is the first time any member of these families have been shown to reduce 
azo compounds.   
Rates of azo bond cleavage were of the same order of magnitude as those previously seen for 
paAzoR1-3 [19]. Interestingly all three enzymes reduced olsalazine which was a compound which 
showed very little reduction by paAzoR1-3 [19]. paArsH in particular shows a propensity for azo dyes 
whose hydrazo-tautomers would form napthoquinones  (e.g. Sudan I and olsalazine). paYieF and 
paMdaB do not show a particular preference for those azo dyes that form either benzo or 
napthoquinones in their hydrazo-tautomers.  
The inclusion of the MdaB enzyme family into the azoreductase family is significant as this family is 
also required for systemic infection of mice in both Helicobacter pylori [20] and Francisella novocida 
[33] as well as P. aeruginosa PA14 [12].  Both paYieF and paArsH have also been shown to be 
required for systemic infection in mice by P. aeruginosa PA14 [12]. This data supports the hypothesis 
that azoreductases are required for bacterial pathogenicity. The reduced infectivity of azoreductase 
gene deletion strains may be related to a reduced ability to survive within host macrophage which 
has been illustrated with azoreductase gene deletion strains of a range of bacteria [34-36].  
paYief is likely to be of particular use to the bioremediation industry due to its unusually high 
thermostability (Table 2) and the fact that members of this family are able to reduce azo bonds. A  
previous study showed that E. coli YieF is able to reduce heavy metal ions such as Cr6+ and U6+ to the 
less water soluble Cr3+ and U3+ [37]. As a result engineered members of the YieF family could well be 
used for bioremediation of both heavy metals and azo dyes. Directed evolution studies have already 
been performed to improve reduction of metals by E. coli YieF [18, 38] it is therefore possible that 
this could also lead to increased azo dye reduction.  
In contrast paWrbA appeared to be unable to reduce any of the azo compounds we have tested 
under any of the conditions used in this study. The enzyme is functional due to its ability to reduce 
quinones (Fig 3A). The enzyme paWrbA is the most distantly related of all of the azoreductase-like 
enzymes thus far identified in P. aeruginosa [1]. When the overall structure of the paWrbA [30] was 
compared to those of classical azoreductases (e.g. paAzoR1) it was found that paWrbA showed some 
major differences (Fig 4). One of the key differences in the two structures is the complete truncation 
in paWrbA of the -hairpin that forms the lid of the paAzoR1 active site. The residues in the -
hairpin have been show to play a crucial role in determining the substrate specificity of 
azoreductases [39]. In paWrbA the “lid” of the active site is formed by Trp99 (Fig 4A) which would be 
able to maintain some of the hydrophobic and - stacking interactions which characterise binding 
of many of the substrates. The lack of the -hairpin structure leads to a much more open active site 
in paWrbA compared to classical azoreductases (Fig 4C vs 4D) which would bind the azo dye much 
more loosely and would lead to poorer rates of reduction. 
Another possible explanation for the lack of azoreduction by paWrbA is a change to an important 
residue in the active site of an azoreductase which is the residue equivalent to Trp105 in E. faecalis 
azoreductase  as site directed mutagenesis has shown that substitutions at this position can 
completely abrogate activity [40]. This residue is an aromatic residue in most azoreductases (Tyr98 
in paAzoR1 – Fig 4b and Tyr96 in E. coli azoreductase) that forms - stacking interactions with FMN 
and also hydrogen bonds with the phosphate group of FMN. As a result this residue plays an 
important role in stabilising the binding of FMN to the protein. Substitution of tryptophan for small 
non-aromatic amino acids was shown to destabilise binding of FMN to E. faecalis azoreductase [40]. 
The effect of substitution to arginine (Arg80), present at this position in paWrbA (Fig 4A), was not 
tested however it is likely to be detrimental as arginine would be unable to form - stacking 
interactions and in the confirmation in the crystal structure is too far (4.8 Å) to form a salt bridge 
interaction with the phosphate group of FMN.  
NAD(P)H quinone oxidoreductase activity 
All four azoreductases were tested for their ability to reduce a range of quinones (Fig 5 and Sup Fig 
2). For the first time paArsH was shown to reduce quinones (Fig 5C). As was recently reported [41], 
paMdaB, paWrbA and paYieF also show quinone reductase activity. As previously shown in paAzoR1-
3 [1] quinone reduction by these enzymes is an order of magnitude faster than reduction of azo 
compounds. This supports the idea that a quinone is more likely to be their physiological substrate.  
paArsH as was noted for azo dye reduction, showed a preference for napthoquinone substrates (Fig 
5C) with the one exception being phenol blue. Both paYieF and paMdaB also show a significant 
preference for napthoquinones e.g. Plu and Men (Fig 5B and D). Unlike paAzoR1-3 which all reduce 
Bzq at a significant rate [1] there is relatively little reduction of Bzq by any of the azoreductases 
tested here.  
The rate of reduction of quinones by paWrbA was slower than that of the other azoreductases 
characterised here and is comparable to the rates of reduction previously observed for paAzoR1 [1]. 
These results proved to be consistent with recently published work by Green et al. [41] where 
paWrbA was shown to be less active than paMdaB and paYieF.   
To determine whether FMN or FAD was the preferred Flavin, the reduction of Phb by the different 
recombinant enzymes was measured in the presence of increasing concentrations of each flavin. Phb 
was selected as the substrate as it is a universal substrate for the enzymes (Fig 5) and reduction was 
measured at 660 nm which would not be confounded by interference from flavin absorbance. 
paWrbA showed a very clear preference for FMN with no reduction observed in the presence of FAD 
at any of the concentrations tested (Fig 6A). This agrees with literature [30] and DSF results (table 1). 
Likewise the increase in rate of reduction of Phb by paArsH with increasing flavin concentration was 
much steeper with FMN than FAD (Fig 6C) agreeing with previous data suggesting that FMN is the 
preferred flavin. The result of addition of either FMN or FAD to paMdaB was very similar (Fig 6D) and 
so it was not possible to determine a preference via this method. Hence there is no reason to doubt 
the preference for FAD which was illustrated by the TLC data (Sup Fig 1). paYieF though is a 
conundrum as the enzymatic assay (Fig 6C) indicates a preference for FMN over FAD. This is 
inconsistent with TLC which showed a weak FAD spot (Sup Fig 1) and DSF where a small but 
significant TM shift was observed upon addition of 1 M FAD (table 2) whereas no change was 
observed with FMN. This data does however support a study by Agarwal et al. [29] where the crystal 
structure was solved in the presence of FMN although no experimental evidence was put forward 
for inclusion of FMN over FAD.       
To help better understand the substrate specificity profiles of paYieF and paMdaB it was necessary 
to compare the structures of their active sites (Fig 7). With this in mind a homology model was 
generated for paMdaB for comparison with the the crystal structures of paAzoR1 (Fig 4B) and 
paYieF. The structure of the active site of paMdaB (Fig 7B) is very similar to that of paAzoR1 (Fig 4A), 
it is a predominantly hydrophobic pocket surrounded by aromatic residues. In paMdaB Thr87 is in a 
similar position to Phe60 in paAzoR1 which has previously been identified to be important for 
determining substrate specificity of azoreductases [42]. In a model of paAzor3 it was suggested that 
the equivalent residue (Thr60), due to its strategic position at one of the entrances to the active site, 
would determine the accessibility to the active site for larger substrates [19]. Both paMdaB (Fig 5D) 
and paAzoR3 [1] show a preference for napthoquinones which would fit with the hypothesis that the 
residue in this position has a gatekeeper role.  
 In comparison, the active site of  paYieF is more open with one side  dominated by the positively 
charged side chain of Arg100 (Fig 4B). The presence of this positive side chain might be expected to 
disrupt the binding of the predominantly hydrophobic substrates however rates of reduction of azo 
and quinone substrates are comparable to those of paMdaB (Figs 3 and 5). A possible explanation 
for this would be the proximity of Glu52 to the guanidinium group of Arg100 (~3 Å) which is likely to 
aid in neutralising the positive charge. The proximity of these charged residues in an otherwise 
hydrophobic environment would facilitate the opposing ionisation states of these residues.  It is 
worth noting that the azoreductase from E. coli (PDB 2Z98 [42]) has Arg59 in a similar position to 
Arg100 and Arg59 was linked to the preference for interaction with specific substrate carboxyl 
groups. 
 
Nitrofurazone reduction 
Nitrorfurazone is a topical antibiotic which is activated by reduction of its nitro group to a 
hydroxylamine which is able to covalently modify DNA [14]. As well as activation by azoreductases 
nitrofurazone can also be activated by more specialised nitroreductases such as NfsB [42]. 
All of the enzymes tested were shown to reduce nitrofurazone. The rate of reduction of 
nitrofurazone by paYieF and paWrbA (Fig 8) are comparable to that measured previously for 
paAzoR1 (Vmax =9.8 M.s
-1.mg of protein-1 under similar experimental conditions [14]). In contrast 
paArsH and paMdaB have rates that are approximately 5 and 3 fold faster respectively.  This is the 
first evidence of nitroreductase activity of these enzymes present in P. aeruginosa as a previous 
study [43] using an indirect readout showed no activity over background during overexpression of 
these enzymes in cancer cell lines.    
 
Conclusions 
The work described here  proves predictions [1] based on bioinformatics analysis that the 
azoreductase family in P. aeruginosa might be significantly larger than originally thought (Table 1). 
This was controversial due to the low sequence homology between some of the predicted enzymes. 
We also show that members of the widely studied bacterial MdaB and YieF families can act as 
azoreductases and identify an NAD(P)H quinone oxidoreductase which does not have azoreductase 
activity.  These two activities are not inextricably linked in all enzymes. As the azoreductases which 
have now been identified are also known to be required for infection, this data paves the way for 
further investigation of their role in bacterial pathogenicity.     
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 Figure list 
Fig 1: Recombinant production of pure azoreductase 
Purity of all recombinant azoreductases after IMAC chromatography determined via SDS-PAGE.   
Fig 2: Nicotinamide selectivity of the azoreductase-like enzymes. 
Enzymatic activities of the following azoreductase-like enzymes (A) paWrbA, (B) paYieF, (C) paArsH, 
(D) paMdaB. Activities were measured using the following substrates Men (A & B) and methyl red (C 
& D) otherwise reactions were performed as described in materials and methods. All experiments 
were performed in triplicate and error bars represent ±standard deviation. Significance was 
measured via a one way ANOVA (p <0.01) using Graphpad Prism.  
Fig 3: Substrate specificity profiles of azoreductases reducing azo dyes. 
Azoreductase activity of the following proteins (A) paYieF, (B) paArsH, (C) paMdaB. Specific activity 
measurements were performed as described in the materials and methods and protein 
concentration was adjusted to maintain a linear rate. All measurements were performed in triplicate 
and error bars represent ±standard deviation.  
Fig 4: A comparison of the active sites of paAzoR1 and paWrbA.  
(A) The structure of the paWrbA active site. (B) The structure of the paAzoR1 active site. (C) 
Electrostatic surface representation of paWrbA. (D) Electrostatic surface representation of paAzoR1. 
In (A) and (B) Each monomer is coloured differently, blue and gold. FMN is shown with yellow carbon 
atoms and side chains are coloured according to the monomer they belong to. All images and 
surfaces were generated in CCP4MG [44] and were based upon PDB files paAzoR1 – 2V9C [5] and 
paWrbA - 1ZWL [30].  
Fig 5: Quinone substrate specificity profiles of azoreductases.  
Each graph represents the NAD(P)H quinone oxidoreductase activity of the following proteins (A) 
paWrbA, (B) paYieF, (C) paArsH, (D) paMdaB. Specific activity measurements were performed as 
described in the materials and methods and protein concentration was adjusted to maintain a linear 
rate. All measurements were carried out in triplicate and error bars represent ±standard deviation.  
Fig 6: Activity assays for all azoreductases in the presence of varying concentrations of flavin. 
The enzymes were as follows (A) paWrbA, (B) paYieF, (C) paArsH, (D) paMdaB. The enzyme 
concentration was kept constant at all concentrations of flavin, paWrbA – 10 g/mL, paYieF - 1 
g/mL, paArsH – 0.2 g/mL and paMdaB - 5 g/mL. Phb reduction was measured by monitoring the 
change in absorbance at 660 nm. Blue symbols show the effect of FMN on activity and red symbols 
show the effect of FAD. All measurements were performed in triplicate and error bars represent 
±standard deviation. 
Fig 7: Comparison of the active sites of paYieF (A), and paMdaB (B). 
The structure of paYieF is based upon X-ray crystallographic data (PDB code 1X77 [29]) whereas 
paMdaB is based upon a homology model generated as described in the materials and methods. In 
both cases monomer A is shown in gold while monomer B is shown in light blue, while FMN (paYieF) 
or FAD (paMdaB) are in yellow. 
 
 
Fig 8: Reduction of nitrofurazone by azoreductases 
All activity measurements were performed as described in the materials and methods section. All 
measurements were carried out in triplicate and error bars represent ±standard deviation. 
Azoreductase Gene code 
paAzoR1# pa0785 
paWrbA* pa0949 
paYieF* pa1204 
paNQO1 pa1224 
paNQO2 pa1225 
paAzoR2# pa1962 
paArsH* pa2280 
paMdaB* pa2580 
paAzoR3# pa3223 
paNQO3 pa4975 
Table 1: List of genes encoding azoreductase-like enzymes in the genome of P. aeruginosa PAO1 
*azoreductases characterised in this manuscript. # previously characterised azoreductases [19]. Gene 
numbers are as listed in the Pseudocap database [45].  
Azoreductase TM /°C TM + FMN /°C TM + FAD /°C 
paWrbA b 55.7 ±0.3 67.4 ±0.8 57.7 ±0.3 
paYieF b 71.1 ±0.6 49.2 ±2 77.3 ±0.5 
paArsH a 47.3 ±0.1 49.1 ±0.7 47.4 ±0.2 
paMdaB a 47.1 ±0.1 52.6 ±0.2 63.5 ±0.1 
Table 2: Binding of flavin cofactors to new azoreductases. 
Changes in protein thermostability are measured in response to addition of either FMN or FAD. a 1 
M or b 20 M flavin. Protein was at 64 g/mL in 20 mM Tris pH 8 100 mM NaCl. All measurements 
were performed in triplicate. 
Sup Fig 1: Reaction scheme for the reduction of olsalazine. 
A general scheme showing the bi-bi ping pong mechanism of reduction of a typical azo compound 
(olsalazine) by flavin dependent azoreductases such as paAzoR1 [39]. 
Sup Fig 2: structures for all substrates used for enzyme characterisation.  
Quinones are abbreviated as follows: Aqn: anthraquinone-2-sulphonate, Bzq: Benzoquinone, Dcb: 
2,5-dichlorobenzoquinone, Ibc: 2,6-dichloroquinone-4-chloromide, Jug: Juglone, Law: Lawsone, 
Men: Menadione, Onq: 1,2-napthoquinone, Phb: Phenol blue and Plu: Plumbagin.  
Sup Fig 3: TLC plates for azoreductases. 
The TLC plates analyse flavin incorporation into the following azoreductase-like enzymes (A) paYieF, 
(B) paMdaB, (C) paArsH and (D) paWrbA.  20 g of enzyme and 2 g of each flavin was spotted onto 
the silica plate. A mobile phase of 2:1:1 N-butanol: acetic acid: water was used to achieve 
separation.  
Sup Fig 4: UV/VIS spectra of azoreductases 
The absorption spectra are for the following azoreductases (A) paYieF, (B) paMdaB, (C) paArsH, (D) 
paWrbA. The absorption spectra for free FMN and FAD are also shown for comparison.  All spectra 
were collected at a protein concentration of 1 mg/mL and a path length of 1 cm.  
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